Moderna’s skin cancer therapy receives new breakthrough after showing promising study results
Moderna Inc said its experimental optimized mRNA skin cancer vaccine in combination with Merck drug Keytruda has received Breakthrough Therapy Designation from US regulators as an add-on treatment for high-risk patients, reports Independent. The drug …